In contrast, in a murine tumor model, IL-1β injection resulted in tumor regression [55], demonstrating that IL-1 can also have anti-tumor effects, for example, via induction of Th1/Th17 responses [10,54]. This evidence concerns the gene IL1A and neoplasm.